Cargando…
A New Strategy to Identify ceRNA-Based CCDC144NL-AS1/SERPINE1 Regulatory Axis as a Novel Prognostic Biomarker for Stomach Adenocarcinoma via High Throughput Transcriptome Data Mining and Computational Verification
Stomach adenocarcinoma (STAD) is one of the most malignant cancers that endanger human health. There is growing evidence that competitive endogenous RNA (ceRNA) regulatory networks play an important role in various human tumors. However, the complexity and behavioral characteristics of the ceRNA net...
Autores principales: | Huang, Zhihong, Liu, Xinkui, Wu, Chao, Lu, Shan, Antony, Stalin, Zhou, Wei, Zhang, Jingyuan, Wu, Zhishan, Tan, Yingying, Fan, Xiaotian, You, Leiming, Jing, Zhiwei, Wu, Jiarui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828946/ https://www.ncbi.nlm.nih.gov/pubmed/35155200 http://dx.doi.org/10.3389/fonc.2021.802727 |
Ejemplares similares
-
Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma
por: Zhai, Yiyan, et al.
Publicado: (2023) -
An Advanced Systems Pharmacology Strategy Reveals AKR1B1, MMP2, PTGER3 as Key Genes in the Competing Endogenous RNA Network of Compound Kushen Injection Treating Gastric Carcinoma by Integrated Bioinformatics and Experimental Verification
por: Zhou, Wei, et al.
Publicado: (2021) -
Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis
por: Lu, Shan, et al.
Publicado: (2023) -
LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940
por: Zhang, Yingying, et al.
Publicado: (2021) -
Long noncoding RNA CCDC144NL-AS1 knockdown induces naïve-like state conversion of human pluripotent stem cells
por: Wang, Yingying, et al.
Publicado: (2019)